A detailed history of First Horizon Advisors, Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 24 shares of RCKT stock, worth $282. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Previous 24 -0.0%
Holding current value
$282
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

SELL
$15.07 - $24.05 $421 - $673
-28 Reduced 53.85%
24 $0
Q4 2022

Feb 10, 2023

BUY
$15.5 - $22.76 $806 - $1,183
52 New
52 $1,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $890M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.